Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ronald E Osman Insider Profile
4 Followers
Ronald E Osman, Director at Biovest International, holds 23.56M shares in Inhibitor Therapeutics (Ticker: INTI), holds ― shares in Biovest International (Ticker: BVTIQ).
Ronald E Osman Biovest International (BVTIQ)Director
Biovest International (BVTIQ)
Director
Not Ranked
Ronald E Osman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director, Ten Percent Owner
Roles that Ronald E Osman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ronald E Osman
Ronald E Osman's Trading History
Biovest International
Aug 21, 2013
―
Uninformative Sell
―
―
Inhibitor Therapeutics
May 16, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$1.44M
List of latest transactions for each holding click on a transaction to see Ronald E Osman's performance on stock
You May Also Like
Ronald E Osman insider profile FAQ
What is the percentage of profitable transactions made by Ronald E Osman?
The percentage of profitable transactions made by Ronald E Osman is ―.
What is the average return per transaction made by Ronald E Osman?
The average return per transaction made by Ronald E Osman is ―.
What stocks does Ronald E Osman hold?
Ronald E Osman holds: BVTIQ, INTI stocks.
What was Ronald E Osman’s latest transaction?
Ronald E Osman latest transaction was an Uninformative Buy of ―.
What was Ronald E Osman's most profitable transaction?
Ronald E Osman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ronald E Osman's role in Biovest International?
Ronald E Osman's role in Biovest International is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.